search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • News
  • News & Events
  • News
  • Thesis defense Meta van Lanschot: towards better surveillance methods for high-risk CRC patients

Thesis defense Meta van Lanschot: towards better surveillance methods for high-risk CRC patients

31-10-2019

On 29 October, Meta van Lanschot from the molecular pathology group of Gerrit Meijer at the NKI defende her thesis, entitled 'Early detection of colorectal cancer. Towards better surveillance'. Meta van Lanschot defended her thesis at  Utrecht University. Promotores: prof. pr. Gerrit Meijer (AVL) en prof. dr. E. Dekker. Co-promotor: prof.dr. B. Carvalho. Her research was funded by the Dutch Cancer Society - Alpe d'Huzes.

Summary

Colorectal cancer (CRC) is a large health problem worldwide. In the Netherlands approximately 14.000 new cases are diagnosed each year. As such, colorectal cancer is the second most common type of cancer. The disease develops from precursor lesions, called polyps, which take an estimated 10 to 15 years to progress to cancer. During colonoscopy polyps can be detected and removed. If diagnosed in an early phase, colorectal cancer is often curable and the treatment burden limited.

Meta Van Lanschot

Those patients in whom colorectal cancer or advanced adenomas have previously been detected, are recommended to undergo regular follow-up colonoscopies. The monitoring of the increased risk population is called surveillance.

In this thesis, results have been generated that contribute to the improvement of the surveillance strategy for early detection of colorectal cancer. On the one hand, molecular changes have been studied that are associated with the progression from polyp to cancer. By understanding better which changes in a polyp will eventually lead to cancer, we may be able to better predict in the future who does and who does not need colonoscopies. On the other hand, alternative surveillance strategies have been tested in clinical practice. Instead of surveillance by colonoscopy, for example stool tests could be used to select patients with a high risk of colorectal cancer or advanced polyps. With the new insights presented, we will hopefully get closer to the implementation of new surveillance strategies that reduce the number of unnecessary colonoscopies and increase the cost-effectiveness of the surveillance programme.

 

Colorectal cancer Early detection

Support our science?

Learn more

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.